Stay updated on Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-01T16:30:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” in agency content.
    Difference
    0.3%
    Check dated 2026-10-25T15:40:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T20:50:05.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-11T20:41:53.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's release version was updated from v3.6.6 to v3.7.0, indicating an underlying platform update for the Record History page. This change does not modify the recorded study history data.
    Difference
    0.1%
    Check dated 2026-09-20T20:05:58.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The record history now shows the study status updated to Completed and the recruitment status set to No longer looking for participants, indicating enrollment has ended.
    Difference
    0.0%
    Check dated 2026-09-13T18:12:10.000Z thumbnail image

Stay in the know with updates to Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.